Your browser doesn't support javascript.
loading
[177Lu]Lu-PSMA Therapy as an Individual Treatment Approach for Patients with High-Grade Glioma: Dosimetry Results and Critical Statement.
Graef, Josefine; Bluemel, Stephanie; Brenner, Winfried; Amthauer, Holger; Truckenmueller, Peter; Kaul, David; Vajkoczy, Peter; Onken, Julia S; Furth, Christian.
Afiliação
  • Graef J; Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany; josefine.graef@charite.de.
  • Bluemel S; Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Brenner W; Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Amthauer H; German Cancer Consortium, Partner Site Berlin, German Cancer Research Center, Heidelberg, Germany.
  • Truckenmueller P; Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Kaul D; Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Vajkoczy P; German Cancer Consortium, Partner Site Berlin, German Cancer Research Center, Heidelberg, Germany.
  • Onken JS; Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, Berlin, Germany; and.
  • Furth C; Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.
J Nucl Med ; 64(6): 892-895, 2023 06.
Article em En | MEDLINE | ID: mdl-37116918

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração / Glioma Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração / Glioma Idioma: En Ano de publicação: 2023 Tipo de documento: Article